Apontis Pharma AG (APPHG)

Currency in EUR
10.85
-0.05(-0.46%)
Closed·
APPHG Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
APPHG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.8510.85
52 wk Range
6.3012.35
Key Statistics
Bid/Ask
10.75 / 10.95
Prev. Close
10.85
Open
10.85
Day's Range
10.85-10.85
52 wk Range
6.3-12.35
Volume
-
Average Volume (3m)
1.96K
1-Year Change
41.64%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
APPHG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.00
Downside
-7.83%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Apontis Pharma AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Apontis Pharma AG Company Profile

Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. As of November 21, 2024, Apontis Pharma AG operates as a subsidiary of Zentiva AG.

Employees
137
Market
Germany

Compare APPHG to Peers and Sector

Metrics to compare
APPHG
Peers
Sector
Relationship
P/E Ratio
120.5x0.3x−0.5x
PEG Ratio
1.130.120.00
Price/Book
2.9x0.5x2.6x
Price / LTM Sales
1.9x2.6x3.3x
Upside (Analyst Target)
−7.8%38.7%41.6%
Fair Value Upside
Unlock19.8%5.9%Unlock

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Strong Sell

Analysts 12-Month Price Target:

Average 10.00
(-7.83% Downside)

Earnings

Latest Release
May 16, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

APPHG Income Statement

FAQ

What Stock Exchange Does Apontis Pharma AG Trade On?

Apontis Pharma AG is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Apontis Pharma AG?

The stock symbol for Apontis Pharma AG is "APPHG."

What Is the Apontis Pharma AG Market Cap?

As of today, Apontis Pharma AG market cap is 90.38M.

What Is Apontis Pharma AG's Earnings Per Share (TTM)?

The Apontis Pharma AG EPS (TTM) is 0.09.

When Is the Next Apontis Pharma AG Earnings Date?

Apontis Pharma AG will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is APPHG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Apontis Pharma AG Stock Split?

Apontis Pharma AG has split 0 times.

How Many Employees Does Apontis Pharma AG Have?

Apontis Pharma AG has 137 employees.

What is the current trading status of Apontis Pharma AG (APPHG)?

As of 13 Aug 2025, Apontis Pharma AG (APPHG) is trading at a price of 10.85, with a previous close of 10.85. The stock has fluctuated within a day range of 10.85 to 10.85, while its 52-week range spans from 6.30 to 12.35.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.